Reference pricing for pharmaceuticals: Is the Australia-United States Free Trade Agreement affecting Australia's Pharmaceutical Benefits Scheme?

Thomas A. Faunce

doi:10.5694/j.1326-5377.2007.tb01209.x

Reference pricing for pharmaceuticals: Is the Australia-United States Free Trade Agreement affecting Australia's Pharmaceutical Benefits Scheme?

Thomas A. Faunce^*

^*Corresponding author for this work

ANU Law School

Research output: Contribution to journal › Article › peer-review

19 Citations (Scopus)

Abstract

Unless the federal government changes the course of our medicines policy with intention, Australia's pricing of patented pharmaceuticals is likely to follow inequitable US trends.

Original language	English
Pages (from-to)	240-242
Number of pages	3
Journal	Medical Journal of Australia
Volume	187
Issue number	4
DOIs	https://doi.org/10.5694/j.1326-5377.2007.tb01209.x
Publication status	Published - 20 Aug 2007

Access to Document

10.5694/j.1326-5377.2007.tb01209.x

Cite this

@article{0ef01388a7394e9da3538e50a844a203,

title = "Reference pricing for pharmaceuticals: Is the Australia-United States Free Trade Agreement affecting Australia's Pharmaceutical Benefits Scheme?",

abstract = "Unless the federal government changes the course of our medicines policy with intention, Australia's pricing of patented pharmaceuticals is likely to follow inequitable US trends.",

author = "Faunce, {Thomas A.}",

year = "2007",

month = aug,

day = "20",

doi = "10.5694/j.1326-5377.2007.tb01209.x",

language = "English",

volume = "187",

pages = "240--242",

journal = "Medical Journal of Australia",

issn = "0025-729X",

publisher = "Australasian Medical Publishing Co. Ltd",

number = "4",

}

TY - JOUR

T1 - Reference pricing for pharmaceuticals

T2 - Is the Australia-United States Free Trade Agreement affecting Australia's Pharmaceutical Benefits Scheme?

AU - Faunce, Thomas A.

PY - 2007/8/20

Y1 - 2007/8/20

N2 - Unless the federal government changes the course of our medicines policy with intention, Australia's pricing of patented pharmaceuticals is likely to follow inequitable US trends.

AB - Unless the federal government changes the course of our medicines policy with intention, Australia's pricing of patented pharmaceuticals is likely to follow inequitable US trends.

UR - http://www.scopus.com/inward/record.url?scp=34848870043&partnerID=8YFLogxK

U2 - 10.5694/j.1326-5377.2007.tb01209.x

DO - 10.5694/j.1326-5377.2007.tb01209.x

M3 - Article

SN - 0025-729X

VL - 187

SP - 240

EP - 242

JO - Medical Journal of Australia

JF - Medical Journal of Australia

IS - 4

ER -

Reference pricing for pharmaceuticals: Is the Australia-United States Free Trade Agreement affecting Australia's Pharmaceutical Benefits Scheme?

Abstract

Access to Document

Other files and links

Fingerprint

Cite this